Status:
NOT_YET_RECRUITING
Prediction of Outcome of Non Invasive Ventilation COPD Patients by Assessment of Diaphragmatic Performance
Lead Sponsor:
Assiut University
Conditions:
Acute Exacerbation COPD
Eligibility:
All Genders
40-90 years
Brief Summary
Transthoracic ultrasonographic assessment of the diaphragmatic performance as a predictor for the outcome of NIV in critically ill COPD patients with acute exacerbation.
Detailed Description
Chronic obstructive pulmonary disease (COPD) is considered a common disease worldwide, and it poses a major health and economic problem. COPD was the fifth leading cause for death in 2022 and will ra...
Eligibility Criteria
Inclusion
- One Hundred fifty five critically ill COPD patients admitted to respiratory intensive care unit
- Diagnosis of COPD and COPD exacerbation is fulfilled according to GOLD 2022 criteria
- Age\>40years
Exclusion
- Age ˂ 40 years.
- Refusal to participate in the study.
- Patients with morbid obesity (BMI\>40).
- Absolute indication for intubation like coma ,hemodynamic instability, or life threatening arrhythmia.
- Contraindication to NIV like untreated pneumothorax, pneumothorax with air leak, widespread facial burn or trauma, tracheotomy, or active upper gastrointestinal bleeding.
Key Trial Info
Start Date :
November 15 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 15 2027
Estimated Enrollment :
155 Patients enrolled
Trial Details
Trial ID
NCT06143150
Start Date
November 15 2023
End Date
December 15 2027
Last Update
November 22 2023
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.